Approval · Notice of Compliance 30998 · 2023
CLARITHROMYCIN: Notice of Compliance 30998
Issued June 15, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 30998
- Date
- June 15, 2023
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Labelling update to match licensor
- Canadian reference product
- BIAXIN BID (Abbott Laboratories Co.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLARITHROMYCIN | Not yet assigned | — |
Medicinal ingredients
- CLARITHROMYCIN 250 MG per TAB
- CLARITHROMYCIN 500 MG per TAB